Rhodium(I)-Catalyzed Annulation of Bicyclo[1.1.0]butyl-Substituted Dihydroquinolines and Dihydropyridines.
Matteo BorginiQi-Nan HuangPan-Pan ChenSteven J GeibKendall N HoukPeter WipfPublished in: Journal of the American Chemical Society (2024)
Bicyclo[1.1.0]butane-containing compounds feature a unique chemical reactivity, trigger "strain-release" reaction cascades, and provide novel scaffolds with considerable utility in the drug discovery field. We report the synthesis of new bicyclo[1.1.0]butane-linked heterocycles by a nucleophilic addition of bicyclo[1.1.0]butyl anions to 8-isocyanatoquinoline, or, alternatively, iminium cations derived from quinolines and pyridines. The resulting bicyclo[1.1.0]butanes are converted with high regioselectivity to unprecedented bridged heterocycles in a rhodium(I)-catalyzed annulative rearrangement. The addition/rearrangement process tolerates a surprisingly large range of functional groups. Subsequent chemo- and stereoselective synthetic transformations of urea, alkene, cyclopropane, and aniline moieties of the 1-methylene-5-azacyclopropa[ cd ]indene scaffolds provide several additional new heterocyclic building blocks. X-ray structure-validated quantum mechanical DFT calculations of the reaction pathway indicate the intermediacy of rhodium carbenoid and metallocyclobutane species.
Keyphrases
- drug discovery
- density functional theory
- ionic liquid
- molecular dynamics
- room temperature
- machine learning
- high resolution
- photodynamic therapy
- deep learning
- magnetic resonance imaging
- magnetic resonance
- computed tomography
- squamous cell carcinoma
- radiation therapy
- quantum dots
- mass spectrometry
- combination therapy